At Mundipharma South Africa, we understand what it means to be a reliable commercial partner. Alliances are at the heart of our development, and we work closely with our partners to build balanced, interest-aligned collaborations focused on creating value - for healthcare systems, for providers and patients, and for all stakeholders.
We are an asset led, customer focused and commercially driven organisation. This drives us to continually pursue innovative new partnerships and opportunities.
The key benefits of establishing a partnership with Mundipharma includes:
Full go-to-market capabilities
We have a strong track record of successful commercial partnerships. Our structure allows for flexibility and fast decision making within a diverse portfolio. We have, to date, successfully brought a number of products to market, and we are currently the market leader in the Schedule 6 analgesic market.
We are part of a broader network of independent associated companies that have a presence in the United States of America, Canada, Australia and across Europe (including the United Kingdom, Germany, France and Spain), Asia, Africa and South America.
We believe in developing, nurturing and maintaining successful and long term alliances with our partners. Our success is attributable to the quality of our people. We are focused and results-driven. As enthusiastic, talented and dedicated individuals, we bring a cohesive, dynamic team, comprising the best talent in the industry, to any partnership.
We understand customer needs and put them at the forefront of everything we do. We are committed to delivering value added products to patients and healthcare professionals at affordable prices, partnering with academic institutions, and working with healthcare funders to demonstrate the economic value of our products.